To assess the relevance of the afore-mentioned results for T-ALL patients in the clinical setting, we evaluated the transcriptional level of CLOCK, BMAL1 and IL20RB genes in a cohort of 264 diagnostic T-ALL patients’ samples from the COG TARGET study [4]. The gene discussed is BMAL1; the disease is acute lymphoblastic leukemia.